nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—Bifonazole—CYP2E1—liver cancer	0.00503	1	CrCbGaD
Letrozole—Erythema multiforme—Sorafenib—liver cancer	0.00313	0.00421	CcSEcCtD
Letrozole—Flushing—Sorafenib—liver cancer	0.00307	0.00413	CcSEcCtD
Letrozole—Cardiac disorder—Sorafenib—liver cancer	0.00307	0.00413	CcSEcCtD
Letrozole—Vaginal haemorrhage—Doxorubicin—liver cancer	0.00304	0.0041	CcSEcCtD
Letrozole—Angiopathy—Sorafenib—liver cancer	0.003	0.00404	CcSEcCtD
Letrozole—Mediastinal disorder—Sorafenib—liver cancer	0.00298	0.00401	CcSEcCtD
Letrozole—Pleural effusion—Doxorubicin—liver cancer	0.00294	0.00396	CcSEcCtD
Letrozole—Rash erythematous—Doxorubicin—liver cancer	0.00294	0.00396	CcSEcCtD
Letrozole—Alopecia—Sorafenib—liver cancer	0.00292	0.00393	CcSEcCtD
Letrozole—Mental disorder—Sorafenib—liver cancer	0.0029	0.0039	CcSEcCtD
Letrozole—Malnutrition—Sorafenib—liver cancer	0.00288	0.00388	CcSEcCtD
Letrozole—Neoplasm malignant—Epirubicin—liver cancer	0.00285	0.00384	CcSEcCtD
Letrozole—Dysgeusia—Sorafenib—liver cancer	0.00282	0.0038	CcSEcCtD
Letrozole—Breast pain—Epirubicin—liver cancer	0.00279	0.00376	CcSEcCtD
Letrozole—Cardiovascular disorder—Epirubicin—liver cancer	0.00277	0.00373	CcSEcCtD
Letrozole—Viral infection—Epirubicin—liver cancer	0.00269	0.00363	CcSEcCtD
Letrozole—Bone disorder—Epirubicin—liver cancer	0.00269	0.00363	CcSEcCtD
Letrozole—Neoplasm malignant—Doxorubicin—liver cancer	0.00264	0.00355	CcSEcCtD
Letrozole—Angioedema—Sorafenib—liver cancer	0.00263	0.00354	CcSEcCtD
Letrozole—Breast pain—Doxorubicin—liver cancer	0.00258	0.00348	CcSEcCtD
Letrozole—Leukopenia—Sorafenib—liver cancer	0.00258	0.00347	CcSEcCtD
Letrozole—Cardiovascular disorder—Doxorubicin—liver cancer	0.00256	0.00345	CcSEcCtD
Letrozole—Bone pain—Epirubicin—liver cancer	0.00254	0.00342	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00252	0.01	CbGpPWpGaD
Letrozole—Cough—Sorafenib—liver cancer	0.00251	0.00338	CcSEcCtD
Letrozole—Bone disorder—Doxorubicin—liver cancer	0.00249	0.00336	CcSEcCtD
Letrozole—Viral infection—Doxorubicin—liver cancer	0.00249	0.00336	CcSEcCtD
Letrozole—Hypertension—Sorafenib—liver cancer	0.00249	0.00335	CcSEcCtD
Letrozole—Musculoskeletal pain—Epirubicin—liver cancer	0.00246	0.00332	CcSEcCtD
Letrozole—Arthralgia—Sorafenib—liver cancer	0.00245	0.0033	CcSEcCtD
Letrozole—Myalgia—Sorafenib—liver cancer	0.00245	0.0033	CcSEcCtD
Letrozole—CYP19A1—FSH signaling pathway—MAPK14—liver cancer	0.00245	0.00971	CbGpPWpGaD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00243	0.00328	CcSEcCtD
Letrozole—Pulmonary embolism—Epirubicin—liver cancer	0.00243	0.00328	CcSEcCtD
Letrozole—Dry mouth—Sorafenib—liver cancer	0.0024	0.00323	CcSEcCtD
Letrozole—Bone pain—Doxorubicin—liver cancer	0.00235	0.00317	CcSEcCtD
Letrozole—Anaphylactic shock—Sorafenib—liver cancer	0.00235	0.00316	CcSEcCtD
Letrozole—Infection—Sorafenib—liver cancer	0.00233	0.00314	CcSEcCtD
Letrozole—Nervous system disorder—Sorafenib—liver cancer	0.0023	0.0031	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—UGDH—liver cancer	0.00229	0.00909	CbGpPWpGaD
Letrozole—Skin disorder—Sorafenib—liver cancer	0.00228	0.00307	CcSEcCtD
Letrozole—Musculoskeletal pain—Doxorubicin—liver cancer	0.00228	0.00307	CcSEcCtD
Letrozole—Pulmonary embolism—Doxorubicin—liver cancer	0.00225	0.00303	CcSEcCtD
Letrozole—Anorexia—Sorafenib—liver cancer	0.00224	0.00302	CcSEcCtD
Letrozole—Rash maculo-papular—Epirubicin—liver cancer	0.00221	0.00298	CcSEcCtD
Letrozole—Neoplasm—Epirubicin—liver cancer	0.0022	0.00296	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00214	0.00288	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00213	0.00844	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.0021	0.00833	CbGpPWpGaD
Letrozole—Dyspnoea—Sorafenib—liver cancer	0.0021	0.00282	CcSEcCtD
Letrozole—Dyspepsia—Sorafenib—liver cancer	0.00207	0.00278	CcSEcCtD
Letrozole—Phlebitis—Epirubicin—liver cancer	0.00205	0.00276	CcSEcCtD
Letrozole—Rash maculo-papular—Doxorubicin—liver cancer	0.00205	0.00276	CcSEcCtD
Letrozole—Decreased appetite—Sorafenib—liver cancer	0.00204	0.00275	CcSEcCtD
Letrozole—Thrombophlebitis—Epirubicin—liver cancer	0.00204	0.00275	CcSEcCtD
Letrozole—Neoplasm—Doxorubicin—liver cancer	0.00204	0.00274	CcSEcCtD
Letrozole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.00204	0.00808	CbGpPWpGaD
Letrozole—Gastrointestinal disorder—Sorafenib—liver cancer	0.00203	0.00273	CcSEcCtD
Letrozole—Fatigue—Sorafenib—liver cancer	0.00203	0.00273	CcSEcCtD
Letrozole—Pain—Sorafenib—liver cancer	0.00201	0.00271	CcSEcCtD
Letrozole—Constipation—Sorafenib—liver cancer	0.00201	0.00271	CcSEcCtD
Letrozole—Gastrointestinal pain—Sorafenib—liver cancer	0.00192	0.00259	CcSEcCtD
Letrozole—Phlebitis—Doxorubicin—liver cancer	0.0019	0.00255	CcSEcCtD
Letrozole—CYP19A1—Tryptophan metabolism—CYP1A1—liver cancer	0.00189	0.0075	CbGpPWpGaD
Letrozole—Hot flush—Epirubicin—liver cancer	0.00189	0.00254	CcSEcCtD
Letrozole—Thrombophlebitis—Doxorubicin—liver cancer	0.00189	0.00254	CcSEcCtD
Letrozole—Increased appetite—Epirubicin—liver cancer	0.00188	0.00253	CcSEcCtD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—liver cancer	0.00188	0.00745	CbGpPWpGaD
Letrozole—Menopausal symptoms—Epirubicin—liver cancer	0.00187	0.00252	CcSEcCtD
Letrozole—Urticaria—Sorafenib—liver cancer	0.00187	0.00251	CcSEcCtD
Letrozole—Body temperature increased—Sorafenib—liver cancer	0.00186	0.0025	CcSEcCtD
Letrozole—Abdominal pain—Sorafenib—liver cancer	0.00186	0.0025	CcSEcCtD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00185	0.00735	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—MTHFR—liver cancer	0.00183	0.00726	CbGpPWpGaD
Letrozole—Cardiac failure—Epirubicin—liver cancer	0.00181	0.00244	CcSEcCtD
Letrozole—Lethargy—Epirubicin—liver cancer	0.0018	0.00243	CcSEcCtD
Letrozole—Cerebrovascular accident—Epirubicin—liver cancer	0.0018	0.00243	CcSEcCtD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.0018	0.00712	CbGpPWpGaD
Letrozole—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00179	0.00709	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—RAF1—liver cancer	0.00178	0.00706	CbGpPWpGaD
Letrozole—Pain in extremity—Epirubicin—liver cancer	0.00177	0.00238	CcSEcCtD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00177	0.007	CbGpPWpGaD
Letrozole—Hot flush—Doxorubicin—liver cancer	0.00175	0.00235	CcSEcCtD
Letrozole—Increased appetite—Doxorubicin—liver cancer	0.00174	0.00234	CcSEcCtD
Letrozole—CYP19A1—FSH signaling pathway—MTOR—liver cancer	0.00174	0.0069	CbGpPWpGaD
Letrozole—Menopausal symptoms—Doxorubicin—liver cancer	0.00173	0.00233	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00173	0.00684	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00169	0.00672	CbGpPWpGaD
Letrozole—Asthenia—Sorafenib—liver cancer	0.00169	0.00227	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—NR1H4—liver cancer	0.00168	0.00667	CbGpPWpGaD
Letrozole—Cardiac failure—Doxorubicin—liver cancer	0.00168	0.00226	CcSEcCtD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00167	0.00663	CbGpPWpGaD
Letrozole—Lethargy—Doxorubicin—liver cancer	0.00167	0.00225	CcSEcCtD
Letrozole—Cerebrovascular accident—Doxorubicin—liver cancer	0.00167	0.00225	CcSEcCtD
Letrozole—Pruritus—Sorafenib—liver cancer	0.00166	0.00224	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—GSTA3—liver cancer	0.00165	0.00656	CbGpPWpGaD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00165	0.00655	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—liver cancer	0.00164	0.00651	CbGpPWpGaD
Letrozole—Pain in extremity—Doxorubicin—liver cancer	0.00163	0.0022	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—GSTA3—liver cancer	0.00163	0.00647	CbGpPWpGaD
Letrozole—Dry skin—Epirubicin—liver cancer	0.00162	0.00218	CcSEcCtD
Letrozole—Diarrhoea—Sorafenib—liver cancer	0.00161	0.00216	CcSEcCtD
Letrozole—Breast disorder—Epirubicin—liver cancer	0.0016	0.00215	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00159	0.00214	CcSEcCtD
Letrozole—Dizziness—Sorafenib—liver cancer	0.00155	0.00209	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00153	0.00607	CbGpPWpGaD
Letrozole—Influenza—Epirubicin—liver cancer	0.00153	0.00206	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—GSTA4—liver cancer	0.00151	0.006	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00151	0.00599	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GSTA3—liver cancer	0.0015	0.00595	CbGpPWpGaD
Letrozole—Dry skin—Doxorubicin—liver cancer	0.0015	0.00202	CcSEcCtD
Letrozole—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.0015	0.00593	CbGpPWpGaD
Letrozole—Vomiting—Sorafenib—liver cancer	0.00149	0.00201	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—GSTA4—liver cancer	0.00149	0.00592	CbGpPWpGaD
Letrozole—Angina pectoris—Epirubicin—liver cancer	0.00149	0.002	CcSEcCtD
Letrozole—Rash—Sorafenib—liver cancer	0.00148	0.00199	CcSEcCtD
Letrozole—Dermatitis—Sorafenib—liver cancer	0.00148	0.00199	CcSEcCtD
Letrozole—Breast disorder—Doxorubicin—liver cancer	0.00148	0.00199	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—GSTA2—liver cancer	0.00147	0.00585	CbGpPWpGaD
Letrozole—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00147	0.00198	CcSEcCtD
Letrozole—Headache—Sorafenib—liver cancer	0.00147	0.00198	CcSEcCtD
Letrozole—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00144	0.00571	CbGpPWpGaD
Letrozole—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00143	0.00568	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AHR—liver cancer	0.00143	0.00566	CbGpPWpGaD
Letrozole—CYP19A1—Ovarian Infertility Genes—CDKN1B—liver cancer	0.00142	0.00565	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTA1—liver cancer	0.00142	0.00564	CbGpPWpGaD
Letrozole—Influenza—Doxorubicin—liver cancer	0.00141	0.0019	CcSEcCtD
Letrozole—Pollakiuria—Epirubicin—liver cancer	0.00141	0.0019	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—NAT2—liver cancer	0.00141	0.00558	CbGpPWpGaD
Letrozole—Nausea—Sorafenib—liver cancer	0.0014	0.00188	CcSEcCtD
Letrozole—Weight increased—Epirubicin—liver cancer	0.00139	0.00187	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—NAT2—liver cancer	0.00139	0.0055	CbGpPWpGaD
Letrozole—Weight decreased—Epirubicin—liver cancer	0.00138	0.00186	CcSEcCtD
Letrozole—Angina pectoris—Doxorubicin—liver cancer	0.00138	0.00185	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00137	0.00545	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GSTA4—liver cancer	0.00137	0.00545	CbGpPWpGaD
Letrozole—Infestation—Epirubicin—liver cancer	0.00136	0.00183	CcSEcCtD
Letrozole—Infestation NOS—Epirubicin—liver cancer	0.00136	0.00183	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—NR1H4—liver cancer	0.00134	0.00531	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GSTA2—liver cancer	0.00134	0.00531	CbGpPWpGaD
Letrozole—Stomatitis—Epirubicin—liver cancer	0.00133	0.00179	CcSEcCtD
Letrozole—Urinary tract infection—Epirubicin—liver cancer	0.00132	0.00178	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—GSTA3—liver cancer	0.00132	0.00522	CbGpPWpGaD
Letrozole—Sweating—Epirubicin—liver cancer	0.00131	0.00176	CcSEcCtD
Letrozole—Pollakiuria—Doxorubicin—liver cancer	0.00131	0.00176	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—GSTA1—liver cancer	0.00129	0.00512	CbGpPWpGaD
Letrozole—Hepatobiliary disease—Epirubicin—liver cancer	0.00129	0.00173	CcSEcCtD
Letrozole—Weight increased—Doxorubicin—liver cancer	0.00129	0.00173	CcSEcCtD
Letrozole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00129	0.0051	CbGpPWpGaD
Letrozole—Weight decreased—Doxorubicin—liver cancer	0.00128	0.00172	CcSEcCtD
Letrozole—Infestation NOS—Doxorubicin—liver cancer	0.00126	0.0017	CcSEcCtD
Letrozole—Infestation—Doxorubicin—liver cancer	0.00126	0.0017	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00124	0.00492	CbGpPWpGaD
Letrozole—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00123	0.00489	CbGpPWpGaD
Letrozole—Haemoglobin—Epirubicin—liver cancer	0.00123	0.00165	CcSEcCtD
Letrozole—Stomatitis—Doxorubicin—liver cancer	0.00123	0.00165	CcSEcCtD
Letrozole—Urinary tract infection—Doxorubicin—liver cancer	0.00122	0.00165	CcSEcCtD
Letrozole—Hepatitis—Epirubicin—liver cancer	0.00122	0.00165	CcSEcCtD
Letrozole—Haemorrhage—Epirubicin—liver cancer	0.00122	0.00165	CcSEcCtD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00122	0.00483	CbGpPWpGaD
Letrozole—Hypoaesthesia—Epirubicin—liver cancer	0.00122	0.00164	CcSEcCtD
Letrozole—Sweating—Doxorubicin—liver cancer	0.00121	0.00163	CcSEcCtD
Letrozole—Urinary tract disorder—Epirubicin—liver cancer	0.00121	0.00163	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—GSTA4—liver cancer	0.0012	0.00478	CbGpPWpGaD
Letrozole—Oedema peripheral—Epirubicin—liver cancer	0.0012	0.00162	CcSEcCtD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.0012	0.00476	CbGpPWpGaD
Letrozole—Connective tissue disorder—Epirubicin—liver cancer	0.0012	0.00162	CcSEcCtD
Letrozole—Urethral disorder—Epirubicin—liver cancer	0.0012	0.00161	CcSEcCtD
Letrozole—Hepatobiliary disease—Doxorubicin—liver cancer	0.00119	0.0016	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—GPX3—liver cancer	0.00118	0.00468	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GSTA2—liver cancer	0.00117	0.00465	CbGpPWpGaD
Letrozole—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00117	0.00464	CbGpPWpGaD
Letrozole—Erythema multiforme—Epirubicin—liver cancer	0.00116	0.00156	CcSEcCtD
Letrozole—Eye disorder—Epirubicin—liver cancer	0.00114	0.00154	CcSEcCtD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00114	0.00452	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—NFE2L2—liver cancer	0.00114	0.00451	CbGpPWpGaD
Letrozole—Haemoglobin—Doxorubicin—liver cancer	0.00114	0.00153	CcSEcCtD
Letrozole—Flushing—Epirubicin—liver cancer	0.00113	0.00153	CcSEcCtD
Letrozole—Cardiac disorder—Epirubicin—liver cancer	0.00113	0.00153	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—GSTA1—liver cancer	0.00113	0.00449	CbGpPWpGaD
Letrozole—Hepatitis—Doxorubicin—liver cancer	0.00113	0.00152	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—liver cancer	0.00113	0.00152	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—liver cancer	0.00113	0.00152	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—HPGDS—liver cancer	0.00112	0.00446	CbGpPWpGaD
Letrozole—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.00112	0.00444	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—NAT2—liver cancer	0.00112	0.00444	CbGpPWpGaD
Letrozole—Urinary tract disorder—Doxorubicin—liver cancer	0.00112	0.0015	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—liver cancer	0.00111	0.0015	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—liver cancer	0.00111	0.0015	CcSEcCtD
Letrozole—Angiopathy—Epirubicin—liver cancer	0.00111	0.00149	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—liver cancer	0.00111	0.00149	CcSEcCtD
Letrozole—Mediastinal disorder—Epirubicin—liver cancer	0.0011	0.00148	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—TGFA—liver cancer	0.00109	0.0043	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GPX3—liver cancer	0.00109	0.0043	CbGpPWpGaD
Letrozole—Alopecia—Epirubicin—liver cancer	0.00108	0.00145	CcSEcCtD
Letrozole—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.00107	0.00426	CbGpPWpGaD
Letrozole—Mental disorder—Epirubicin—liver cancer	0.00107	0.00144	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—SERPINA1—liver cancer	0.00107	0.00424	CbGpPWpGaD
Letrozole—Erythema multiforme—Doxorubicin—liver cancer	0.00107	0.00144	CcSEcCtD
Letrozole—Malnutrition—Epirubicin—liver cancer	0.00106	0.00143	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—liver cancer	0.00106	0.00142	CcSEcCtD
Letrozole—Flushing—Doxorubicin—liver cancer	0.00105	0.00141	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—liver cancer	0.00105	0.00141	CcSEcCtD
Letrozole—Tension—Epirubicin—liver cancer	0.00104	0.00141	CcSEcCtD
Letrozole—Dysgeusia—Epirubicin—liver cancer	0.00104	0.0014	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00104	0.00412	CbGpPWpGaD
Letrozole—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00103	0.0041	CbGpPWpGaD
Letrozole—Nervousness—Epirubicin—liver cancer	0.00103	0.00139	CcSEcCtD
Letrozole—Back pain—Epirubicin—liver cancer	0.00103	0.00139	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—liver cancer	0.00103	0.00138	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—liver cancer	0.00102	0.00137	CcSEcCtD
Letrozole—Vision blurred—Epirubicin—liver cancer	0.001	0.00135	CcSEcCtD
Letrozole—Alopecia—Doxorubicin—liver cancer	0.000999	0.00135	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—liver cancer	0.000991	0.00133	CcSEcCtD
Letrozole—Ill-defined disorder—Epirubicin—liver cancer	0.000987	0.00133	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000987	0.00391	CbGpPWpGaD
Letrozole—Malnutrition—Doxorubicin—liver cancer	0.000985	0.00133	CcSEcCtD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000979	0.00388	CbGpPWpGaD
Letrozole—Tension—Doxorubicin—liver cancer	0.000966	0.0013	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—liver cancer	0.000964	0.0013	CcSEcCtD
Letrozole—Malaise—Epirubicin—liver cancer	0.00096	0.00129	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—liver cancer	0.000956	0.00129	CcSEcCtD
Letrozole—Vertigo—Epirubicin—liver cancer	0.000956	0.00129	CcSEcCtD
Letrozole—Leukopenia—Epirubicin—liver cancer	0.000953	0.00128	CcSEcCtD
Letrozole—Back pain—Doxorubicin—liver cancer	0.000952	0.00128	CcSEcCtD
Letrozole—Palpitations—Epirubicin—liver cancer	0.00094	0.00127	CcSEcCtD
Letrozole—Cough—Epirubicin—liver cancer	0.000929	0.00125	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—liver cancer	0.000928	0.00125	CcSEcCtD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000925	0.00367	CbGpPWpGaD
Letrozole—Hypertension—Epirubicin—liver cancer	0.000919	0.00124	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—CYP2E1—liver cancer	0.000917	0.00364	CbGpPWpGaD
Letrozole—Ill-defined disorder—Doxorubicin—liver cancer	0.000914	0.00123	CcSEcCtD
Letrozole—Myalgia—Epirubicin—liver cancer	0.000906	0.00122	CcSEcCtD
Letrozole—Arthralgia—Epirubicin—liver cancer	0.000906	0.00122	CcSEcCtD
Letrozole—Chest pain—Epirubicin—liver cancer	0.000906	0.00122	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—CYP2E1—liver cancer	0.000904	0.00359	CbGpPWpGaD
Letrozole—Anxiety—Epirubicin—liver cancer	0.000903	0.00122	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.0009	0.00121	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—HPGDS—liver cancer	0.000895	0.00355	CbGpPWpGaD
Letrozole—Discomfort—Epirubicin—liver cancer	0.000895	0.0012	CcSEcCtD
Letrozole—Malaise—Doxorubicin—liver cancer	0.000888	0.0012	CcSEcCtD
Letrozole—Dry mouth—Epirubicin—liver cancer	0.000886	0.00119	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—liver cancer	0.000885	0.00119	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—liver cancer	0.000881	0.00119	CcSEcCtD
Letrozole—Palpitations—Doxorubicin—liver cancer	0.00087	0.00117	CcSEcCtD
Letrozole—Oedema—Epirubicin—liver cancer	0.000868	0.00117	CcSEcCtD
Letrozole—Anaphylactic shock—Epirubicin—liver cancer	0.000868	0.00117	CcSEcCtD
Letrozole—CYP19A1—FSH signaling pathway—AKT1—liver cancer	0.000866	0.00343	CbGpPWpGaD
Letrozole—Infection—Epirubicin—liver cancer	0.000863	0.00116	CcSEcCtD
Letrozole—Cough—Doxorubicin—liver cancer	0.000859	0.00116	CcSEcCtD
Letrozole—Nervous system disorder—Epirubicin—liver cancer	0.000852	0.00115	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—liver cancer	0.00085	0.00114	CcSEcCtD
Letrozole—Tachycardia—Epirubicin—liver cancer	0.000848	0.00114	CcSEcCtD
Letrozole—Skin disorder—Epirubicin—liver cancer	0.000844	0.00114	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—GGT1—liver cancer	0.000842	0.00334	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000841	0.00333	CbGpPWpGaD
Letrozole—Hyperhidrosis—Epirubicin—liver cancer	0.00084	0.00113	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—liver cancer	0.000838	0.00113	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—liver cancer	0.000838	0.00113	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—liver cancer	0.000838	0.00113	CcSEcCtD
Letrozole—Anxiety—Doxorubicin—liver cancer	0.000835	0.00112	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000832	0.00112	CcSEcCtD
Letrozole—Discomfort—Doxorubicin—liver cancer	0.000828	0.00111	CcSEcCtD
Letrozole—Anorexia—Epirubicin—liver cancer	0.000828	0.00111	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ABL1—liver cancer	0.00082	0.00325	CbGpPWpGaD
Letrozole—Dry mouth—Doxorubicin—liver cancer	0.00082	0.0011	CcSEcCtD
Letrozole—Oedema—Doxorubicin—liver cancer	0.000804	0.00108	CcSEcCtD
Letrozole—Anaphylactic shock—Doxorubicin—liver cancer	0.000804	0.00108	CcSEcCtD
Letrozole—Infection—Doxorubicin—liver cancer	0.000798	0.00107	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000791	0.00107	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—liver cancer	0.000788	0.00106	CcSEcCtD
Letrozole—Insomnia—Epirubicin—liver cancer	0.000785	0.00106	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—liver cancer	0.000784	0.00106	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—liver cancer	0.000781	0.00105	CcSEcCtD
Letrozole—Paraesthesia—Epirubicin—liver cancer	0.00078	0.00105	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—liver cancer	0.000777	0.00105	CcSEcCtD
Letrozole—Dyspnoea—Epirubicin—liver cancer	0.000774	0.00104	CcSEcCtD
Letrozole—Somnolence—Epirubicin—liver cancer	0.000772	0.00104	CcSEcCtD
Letrozole—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000768	0.00305	CbGpPWpGaD
Letrozole—Anorexia—Doxorubicin—liver cancer	0.000766	0.00103	CcSEcCtD
Letrozole—Dyspepsia—Epirubicin—liver cancer	0.000764	0.00103	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—GGT1—liver cancer	0.000764	0.00303	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTP1—liver cancer	0.000756	0.003	CbGpPWpGaD
Letrozole—Decreased appetite—Epirubicin—liver cancer	0.000755	0.00102	CcSEcCtD
Letrozole—Gastrointestinal disorder—Epirubicin—liver cancer	0.00075	0.00101	CcSEcCtD
Letrozole—Fatigue—Epirubicin—liver cancer	0.000749	0.00101	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—GSTP1—liver cancer	0.000746	0.00296	CbGpPWpGaD
Letrozole—Pain—Epirubicin—liver cancer	0.000743	0.001	CcSEcCtD
Letrozole—Constipation—Epirubicin—liver cancer	0.000743	0.001	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000732	0.000986	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—CYP2E1—liver cancer	0.00073	0.00289	CbGpPWpGaD
Letrozole—Insomnia—Doxorubicin—liver cancer	0.000727	0.000978	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—liver cancer	0.000722	0.000971	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—liver cancer	0.000716	0.000964	CcSEcCtD
Letrozole—Feeling abnormal—Epirubicin—liver cancer	0.000716	0.000963	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—liver cancer	0.000714	0.000962	CcSEcCtD
Letrozole—Gastrointestinal pain—Epirubicin—liver cancer	0.00071	0.000956	CcSEcCtD
Letrozole—Dyspepsia—Doxorubicin—liver cancer	0.000707	0.000952	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—liver cancer	0.000699	0.00094	CcSEcCtD
Letrozole—CYP2A6—Fluoropyrimidine Activity—TP53—liver cancer	0.000695	0.00276	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTM1—liver cancer	0.000695	0.00276	CbGpPWpGaD
Letrozole—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000694	0.000934	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—liver cancer	0.000693	0.000933	CcSEcCtD
Letrozole—Urticaria—Epirubicin—liver cancer	0.00069	0.000929	CcSEcCtD
Letrozole—Pain—Doxorubicin—liver cancer	0.000687	0.000925	CcSEcCtD
Letrozole—Constipation—Doxorubicin—liver cancer	0.000687	0.000925	CcSEcCtD
Letrozole—Body temperature increased—Epirubicin—liver cancer	0.000687	0.000924	CcSEcCtD
Letrozole—Abdominal pain—Epirubicin—liver cancer	0.000687	0.000924	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—GSTP1—liver cancer	0.000686	0.00272	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—GSTM1—liver cancer	0.000685	0.00272	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—HMOX1—liver cancer	0.000677	0.00268	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00067	0.00266	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GGT1—liver cancer	0.00067	0.00266	CbGpPWpGaD
Letrozole—Feeling abnormal—Doxorubicin—liver cancer	0.000662	0.000891	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—CYP1A1—liver cancer	0.000659	0.00261	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Doxorubicin—liver cancer	0.000657	0.000885	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—CYP1A1—liver cancer	0.00065	0.00258	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000646	0.00256	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000643	0.00255	CbGpPWpGaD
Letrozole—Urticaria—Doxorubicin—liver cancer	0.000638	0.000859	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—liver cancer	0.000635	0.000855	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—liver cancer	0.000635	0.000855	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—GSTM1—liver cancer	0.000631	0.0025	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—HGF—liver cancer	0.000631	0.0025	CbGpPWpGaD
Letrozole—Asthenia—Epirubicin—liver cancer	0.000623	0.000839	CcSEcCtD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000621	0.00246	CbGpPWpGaD
Letrozole—Pruritus—Epirubicin—liver cancer	0.000614	0.000827	CcSEcCtD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000613	0.00243	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—liver cancer	0.000606	0.0024	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GSTP1—liver cancer	0.000602	0.00239	CbGpPWpGaD
Letrozole—Diarrhoea—Epirubicin—liver cancer	0.000594	0.0008	CcSEcCtD
Letrozole—Asthenia—Doxorubicin—liver cancer	0.000577	0.000776	CcSEcCtD
Letrozole—Dizziness—Epirubicin—liver cancer	0.000574	0.000773	CcSEcCtD
Letrozole—Pruritus—Doxorubicin—liver cancer	0.000569	0.000765	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—GSTM1—liver cancer	0.000553	0.00219	CbGpPWpGaD
Letrozole—Vomiting—Epirubicin—liver cancer	0.000552	0.000743	CcSEcCtD
Letrozole—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000552	0.00219	CbGpPWpGaD
Letrozole—Diarrhoea—Doxorubicin—liver cancer	0.00055	0.00074	CcSEcCtD
Letrozole—Rash—Epirubicin—liver cancer	0.000548	0.000737	CcSEcCtD
Letrozole—Dermatitis—Epirubicin—liver cancer	0.000547	0.000736	CcSEcCtD
Letrozole—Headache—Epirubicin—liver cancer	0.000544	0.000732	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.000538	0.00213	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000532	0.00211	CbGpPWpGaD
Letrozole—Dizziness—Doxorubicin—liver cancer	0.000531	0.000715	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.000527	0.00209	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP1A1—liver cancer	0.000524	0.00208	CbGpPWpGaD
Letrozole—Nausea—Epirubicin—liver cancer	0.000516	0.000694	CcSEcCtD
Letrozole—Vomiting—Doxorubicin—liver cancer	0.000511	0.000688	CcSEcCtD
Letrozole—Rash—Doxorubicin—liver cancer	0.000507	0.000682	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—liver cancer	0.000506	0.000681	CcSEcCtD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000504	0.002	CbGpPWpGaD
Letrozole—Headache—Doxorubicin—liver cancer	0.000503	0.000678	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000494	0.00196	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—UGDH—liver cancer	0.000493	0.00195	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000491	0.00195	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000483	0.00191	CbGpPWpGaD
Letrozole—Nausea—Doxorubicin—liver cancer	0.000477	0.000643	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000476	0.00189	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—EPT1—liver cancer	0.000463	0.00184	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000446	0.00177	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000442	0.00175	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000441	0.00175	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TAT—liver cancer	0.000439	0.00174	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.000439	0.00174	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000436	0.00173	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000432	0.00171	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.00043	0.00171	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000415	0.00165	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000411	0.00163	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000405	0.00161	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.000404	0.0016	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.000393	0.00156	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—UGDH—liver cancer	0.000392	0.00156	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—JUN—liver cancer	0.000392	0.00155	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.000389	0.00154	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—EPT1—liver cancer	0.000369	0.00146	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000362	0.00144	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TAT—liver cancer	0.000349	0.00139	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000344	0.00137	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.000342	0.00136	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000328	0.0013	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000323	0.00128	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—liver cancer	0.000315	0.00125	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GLUL—liver cancer	0.000298	0.00118	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CPT1B—liver cancer	0.000298	0.00118	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.000291	0.00115	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NR1H4—liver cancer	0.000288	0.00114	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTA3—liver cancer	0.000283	0.00112	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000268	0.00106	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000264	0.00105	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTA4—liver cancer	0.000259	0.00103	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—liver cancer	0.000259	0.00103	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—TGFB1—liver cancer	0.000257	0.00102	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000253	0.001	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTA2—liver cancer	0.000252	0.001	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000246	0.000974	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTA1—liver cancer	0.000243	0.000965	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NAT2—liver cancer	0.000241	0.000954	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CPT1B—liver cancer	0.000238	0.000942	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GLUL—liver cancer	0.000238	0.000942	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000231	0.000917	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALDOB—liver cancer	0.000231	0.000915	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NR1H4—liver cancer	0.000229	0.000908	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTA3—liver cancer	0.000225	0.000893	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000221	0.000875	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CRABP1—liver cancer	0.00022	0.000873	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000218	0.000866	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000218	0.000863	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTA4—liver cancer	0.000206	0.000817	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000203	0.000804	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTA2—liver cancer	0.000201	0.000796	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.0002	0.000793	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000198	0.000786	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTA1—liver cancer	0.000194	0.000768	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HPGDS—liver cancer	0.000192	0.000763	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000192	0.000762	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NAT2—liver cancer	0.000191	0.000759	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000191	0.000758	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.00019	0.000752	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALDOB—liver cancer	0.000184	0.000728	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CRABP1—liver cancer	0.000175	0.000695	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000174	0.000691	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000172	0.000682	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PSMA4—liver cancer	0.000171	0.00068	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PSMD10—liver cancer	0.000171	0.00068	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GOT2—liver cancer	0.000167	0.000661	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2E1—liver cancer	0.000157	0.000622	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HPGDS—liver cancer	0.000153	0.000607	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000152	0.000602	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYCS—liver cancer	0.000147	0.000582	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GGT1—liver cancer	0.000144	0.000571	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GOT1—liver cancer	0.000144	0.000571	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UGDH—liver cancer	0.000144	0.00057	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PSMA4—liver cancer	0.000136	0.000541	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PSMD10—liver cancer	0.000136	0.000541	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—EPT1—liver cancer	0.000135	0.000536	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GOT2—liver cancer	0.000133	0.000526	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTP1—liver cancer	0.000129	0.000513	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TAT—liver cancer	0.000128	0.000508	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMOX1—liver cancer	0.000128	0.000506	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2E1—liver cancer	0.000125	0.000495	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTM1—liver cancer	0.000119	0.000471	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYCS—liver cancer	0.000117	0.000463	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GOT1—liver cancer	0.000115	0.000454	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GGT1—liver cancer	0.000115	0.000454	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1A1—liver cancer	0.000113	0.000447	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTHFR—liver cancer	0.000105	0.000416	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARA—liver cancer	0.000103	0.000409	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTP1—liver cancer	0.000103	0.000408	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMOX1—liver cancer	0.000102	0.000403	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTM1—liver cancer	9.46e-05	0.000375	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.25e-05	0.000367	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1A1—liver cancer	8.97e-05	0.000356	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CG—liver cancer	8.82e-05	0.00035	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GLUL—liver cancer	8.71e-05	0.000345	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CPT1B—liver cancer	8.71e-05	0.000345	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARG—liver cancer	8.52e-05	0.000338	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NR1H4—liver cancer	8.4e-05	0.000333	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTHFR—liver cancer	8.36e-05	0.000331	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA3—liver cancer	8.26e-05	0.000327	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARA—liver cancer	8.2e-05	0.000325	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CD—liver cancer	7.76e-05	0.000308	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALB—liver cancer	7.66e-05	0.000304	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA4—liver cancer	7.55e-05	0.0003	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA2—liver cancer	7.36e-05	0.000292	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA1—liver cancer	7.1e-05	0.000282	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CG—liver cancer	7.02e-05	0.000279	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NAT2—liver cancer	7.02e-05	0.000278	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARG—liver cancer	6.78e-05	0.000269	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CB—liver cancer	6.76e-05	0.000268	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALDOB—liver cancer	6.73e-05	0.000267	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CRABP1—liver cancer	6.42e-05	0.000255	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CD—liver cancer	6.17e-05	0.000245	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALB—liver cancer	6.09e-05	0.000242	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HPGDS—liver cancer	5.61e-05	0.000223	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CB—liver cancer	5.38e-05	0.000213	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PSMA4—liver cancer	5e-05	0.000198	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PSMD10—liver cancer	5e-05	0.000198	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GOT2—liver cancer	4.87e-05	0.000193	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2E1—liver cancer	4.58e-05	0.000181	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYCS—liver cancer	4.28e-05	0.00017	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GOT1—liver cancer	4.2e-05	0.000167	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GGT1—liver cancer	4.2e-05	0.000167	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CA—liver cancer	4.12e-05	0.000163	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTP1—liver cancer	3.77e-05	0.00015	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMOX1—liver cancer	3.72e-05	0.000148	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM1—liver cancer	3.47e-05	0.000138	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—liver cancer	3.37e-05	0.000134	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1A1—liver cancer	3.29e-05	0.00013	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CA—liver cancer	3.28e-05	0.00013	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTHFR—liver cancer	3.06e-05	0.000122	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARA—liver cancer	3.01e-05	0.000119	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—liver cancer	2.68e-05	0.000106	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CG—liver cancer	2.57e-05	0.000102	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARG—liver cancer	2.49e-05	9.86e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CD—liver cancer	2.26e-05	8.98e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALB—liver cancer	2.23e-05	8.86e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CB—liver cancer	1.97e-05	7.82e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CA—liver cancer	1.2e-05	4.77e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—liver cancer	9.83e-06	3.9e-05	CbGpPWpGaD
